These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2473972)

  • 1. Tumor cell permeability to peplomycin.
    Kuramochi H; Takahashi K; Takeuchi T
    J Antibiot (Tokyo); 1989 Jul; 42(7):1163-70. PubMed ID: 2473972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the cytotoxicity of the antitumor antibiotic peplomycin by membrane-interacting drugs and by increased levels of calcium ions.
    Mizuno S; Ishida A; Uehara Y; Nanjo T
    Gan; 1983 Oct; 74(5):767-76. PubMed ID: 6196250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity to antitumor drugs and vinblastine binding to membrane in rat ascites hepatoma AH66 cells.
    Wakusawa S; Nakamura S; Inoko K; Miyamoto K
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2182-4. PubMed ID: 1423778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effect of an antineoplastic agent (peplomycin) adsorbed on activated charcoal (PEP-AC)].
    Ekimoto H; Yamashita T; Takahashi K; Matsuda A; Nagahama F
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1380-6. PubMed ID: 6191713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell killing mode of liblomycin (NK313), a novel dose-survival relationship different from bleomycins.
    Kuramochi-Motegi A; Kuramochi H; Takahashi K; Takeuchi T
    J Antibiot (Tokyo); 1991 Apr; 44(4):429-34. PubMed ID: 1709630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of naturally acquired multiple-drug resistance of Yoshida rat ascites hepatoma AH66 cell line.
    Miyamoto K; Wakabayashi D; Minamino T; Nomura M; Wakusawa S; Nakamura S
    Anticancer Res; 1996; 16(3A):1235-40. PubMed ID: 8702243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peplomycin sensitivity of various types of human gynecological cultured tumor cells].
    Ueda M; Nozawa S; Ueki M; Sano T; Nagai S; Sugimoto O; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1867-76. PubMed ID: 6209350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of vinblastine accumulation by inhibitors of calmodulin-dependent cell functions in rat ascites hepatoma AH66 cells.
    Wakusawa S; Takeda K; Miyamoto K; Hidaka H
    Anticancer Res; 1992; 12(6B):2021-4. PubMed ID: 1363514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms affecting peplomycin sensitivity of Chinese hamster cell lines.
    Ozawa S; Tamura A; Suzuki H; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1985 Sep; 38(9):1257-65. PubMed ID: 2415503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells.
    Miyamoto KI; Koga-Takeda K; Koga K; Ohshima T; Nomura M
    J Pharm Pharmacol; 1996 May; 48(5):522-5. PubMed ID: 8799879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytostatic and cytotoxic response of Ehrlich ascites tumor cells in vivo on chronic treatment with cytarabine, bleomycin, and peplomycin.
    Stoehr M; Friedel G; Engel P; Goerttler K; Futterman G
    Arzneimittelforschung; 1984; 34(4):451-4. PubMed ID: 6204650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution study of peplomycin in rat kidney revealed by immunocytochemistry using monoclonal antibodies.
    Fujiwara K; Shin M; Hougaard DM; Saita T
    Histochem Cell Biol; 2011 Jan; 135(1):93-101. PubMed ID: 21153656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance in Yoshida rat ascites hepatoma cell lines.
    Miyamoto K; Wakusawa S; Nakamura S; Tajima K; Hidaka H
    Anticancer Res; 1992; 12(3):649-53. PubMed ID: 1622121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo cisplatin resistance of rat ascites hepatoma AH66.
    Minamino T; Nomura M; Tamai M; Moritani S; Ohshima T; Miyamoto K
    Cancer Lett; 1996 Nov; 108(2):153-6. PubMed ID: 8973588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labelled bleomycin as a tumour-localizing agent. II. The effect of dose loading of the different forms of 57Cobalt-bleomycin A2, B2, and pepleomycin on the tissue distribution and tumour uptake in tumour-bearing rats.
    Vos CM; Westera G
    Eur J Nucl Med; 1982; 7(2):92-4. PubMed ID: 6177534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies on the combined cytotoxic effect of forskolin with mitomycin C and responsiveness to forskolin in rat ascites hepatoma AH66 cells and AH66F cells.
    Miyamoto K; Matsunaga T; Koshiura R; Takagi K; Satake T; Hasegawa T
    J Pharmacobiodyn; 1987 Jul; 10(7):346-52. PubMed ID: 2826750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two types of lethal damage induced by pepleomycin in cultured Chinese hamster V79 cells.
    Saito T; Kamata R; Okada S
    Gan; 1984 Feb; 75(2):143-50. PubMed ID: 6203804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted killing of squamous carcinoma cells by a monoclonal antibody-peplomycin conjugate which recognizes the EGF receptor.
    Osaku M; Ueda M; Ando N; Shinozawa Y; Hirota N; Shimizu N; Abe O
    Anticancer Res; 1991; 11(6):1951-6. PubMed ID: 1723259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of filipin, a polyene antibiotic, on human tumor cell killing in vitro by peplomycin].
    Urade M; Sugi M; Igarashi T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3244-50. PubMed ID: 2430525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forskolin inhibits the Gs-stimulated adenylate cyclase in rat ascites hepatoma AH66F cells.
    Miyamoto K; Sanae F; Koshiura R; Matsunaga T; Hasegawa T; Takagi K; Satake T
    Exp Cell Res; 1989 Sep; 184(1):219-27. PubMed ID: 2551705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.